dorsaVi Ltd develops and sells motion analysis technologies in Australia, Europe, and the United States. It operates through three segments: Clinical, Workplace, and RRAM. The company provides ViMove+, a clinical and sports solutions; VideoAI, a visual movement data; ViSafe+, a measure movement, identify risk, and support proactive safety programs; and Research+, a precision tools for movement research. It serves clinic and sports, workplace, and research industries. dorsaVi Ltd was incorporated in 2008 and is based in Oakleigh South, Australia.
Research context
dorsaVi Ltd appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Technology
- Industry
- Scientific & Technical Instruments
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
dorsaVi Ltd is currently in a long term downtrend where the price is trading 11.2% below its 200 day moving average.
From a valuation standpoint, the stock is 92.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 5.4.
dorsaVi Ltd's total revenue sank by 35.0% to $820K since the same quarter in the previous year.
Its net income has increased by 94.4% to $-327K since the same quarter in the previous year.
Finally, its free cash flow grew by 69.3% to $-316K since the same quarter in the previous year.
Based on the above factors, dorsaVi Ltd gets an overall score of 3/5.